Du er her: Forside / intranet / orphafolder

orphaentry | 363623 | Autosomal recessive limb-girdle muscular dystrophy type 2T
orphaentry | 363649 | Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome
orphaentry | 363654 | X-linked parkinsonism-spasticity syndrome
orphaentry | 363659 | 20q11.2 microduplication syndrome
orphaentry | 363665 | Acroosteolysis-keloid-like lesions-premature aging syndrome
orphaentry | 363540 | Leukoencephalopathy with mild cerebellar ataxia and white matter edema
orphaentry | 363543 | Autosomal recessive limb-girdle muscular dystrophy type 2R
orphaentry | 363549 | Acute encephalopathy with biphasic seizures and late reduced diffusion
orphaentry text/h323 | 363558 | New-onset refractory status epilepticus
orphaentry | 363567 | Acute encephalopathy with inflammation-mediated status epilepticus
orphaentry | 363579 | Extragonadal germ cell tumor
orphaentry | 363582 | Gonadal germ cell tumor
orphaentry | 363611 | Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome
orphaentry | 363504 | Germ cell tumor of testis
orphaentry | 363494 | Non-seminomatous germ cell tumor of testis
orphaentry | 363523 | Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
orphaentry | 363534 | Mitochondrial DNA depletion syndrome, hepatocerebrorenal form
orphaentry | 363528 | Intellectual disability-strabismus syndrome
orphaentry | 363444 | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome
orphaentry | 363454 | BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy
orphaentry | 363447 | Autosomal dominant childhood-onset proximal spinal muscular atrophy
orphaentry | 363478 | Paratesticular adenocarcinoma
orphaentry | 363472 | Tumor of testis and paratestis
orphaentry | 363489 | Sex cord-stromal tumor of testis
orphaentry | 363483 | Testicular teratoma
orphaentry | 357175 | Short ulna-dysmorphism-hypotonia-intellectual disability syndrome
orphaentry | 357191 | Selection of therapeutic option in non-small cell lung carcinoma
orphaentry | 357194 | Selection of therapeutic option in colorectal cancer
orphaentry | 357329 | Combined immunodeficiency due to IL21R deficiency
orphaentry | 357332 | Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome
orphaentry | 357220 | Primary essential cutis verticis gyrata
orphaentry | 357225 | Primary non-essential cutis verticis gyrata
orphaentry | 357237 | Severe combined immunodeficiency due to CARD11 deficiency
orphaentry | 357506 | Genetic non-syndromic renal or urinary tract malformation
orphaentry | 357502 | Idiopathic nephrotic syndrome
orphaentry | 356978 | D,L-2-hydroxyglutaric aciduria
orphaentry | 356947 | 3q26q27 microdeletion syndrome
orphaentry | 356961 | SLC35A2-CDG
orphaentry | 357008 | Atypical hemolytic-uremic syndrome with DGKE deficiency
orphaentry | 357001 | 19p13.13 microdeletion syndrome
orphaentry | 356996 | ANK3-related intellectual disability-sleep disturbance syndrome
orphaentry | 357043 | Amyotrophic lateral sclerosis type 4
orphaentry | 357034 | Non-hereditary retinoblastoma
orphaentry | 357027 | Hereditary retinoblastoma
orphaentry | 357074 | Autosomal recessive cutis laxa type 2, classic type
orphaentry | 357064 | Autosomal recessive cutis laxa type 2B
orphaentry | 357058 | Autosomal recessive cutis laxa type 2A
orphaentry | 357158 | Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome
orphaentry | 357154 | Oral submucous fibrosis
orphaentry | 357131 | Venous thoracic outlet syndrome
orphaentry | 357107 | Arterial thoracic outlet syndrome
orphaentry | 352654 | Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome
orphaentry | 352662 | Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome
orphaentry | 352657 | Hereditary benign intraepithelial dyskeratosis
orphaentry | 352641 | Autosomal recessive cerebellar ataxia with late-onset spasticity
orphaentry | 352636 | Phalangeal microgeodic syndrome
orphaentry | 352649 | Brain dopamine-serotonin vesicular transport disease
orphaentry | 352596 | Progressive myoclonic epilepsy with dystonia
orphaentry | 352629 | 16q24.1 microdeletion syndrome
orphaentry | 352613 | Male infertility due to NANOS1 mutation
orphaentry | 352577 | Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
orphaentry | 352587 | Focal epilepsy-intellectual disability-cerebro-cerebellar malformation
orphaentry | 352582 | Familial infantile myoclonic epilepsy
orphaentry | 352728 | Disorder of melanin metabolism
orphaentry | 352731 | Oculocutaneous albinism type 1
orphaentry | 352734 | Minimal pigment oculocutaneous albinism type 1
orphaentry | 352737 | Temperature-sensitive oculocutaneous albinism type 1
orphaentry | 352709 | CLN13 disease
orphaentry | 352712 | Facial dysmorphism-immunodeficiency-livedo-short stature syndrome
orphaentry | 352718 | Progressive retinal dystrophy due to retinol transport defect
orphaentry | 352723 | Attenuated Chédiak-Higashi syndrome
orphaentry | 352687 | Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies
orphaentry | 352665 | Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion
orphaentry | 352670 | Autosomal dominant intermediate Charcot-Marie-Tooth disease type F
orphaentry | 352675 | X-linked Charcot-Marie-Tooth disease type 6
orphaentry | 352682 | Cobblestone lissencephaly without muscular or ocular involvement
orphaentry | 353277 | Rubinstein-Taybi syndrome due to CREBBP mutations
orphaentry | 353220 | Familial primary localized cutaneous amyloidosis
orphaentry | 353217 | Epileptic encephalopathy with global cerebral demyelination
orphaentry | 352763 | Scleredema
orphaentry | 352745 | Oculocutaneous albinism type 7
orphaentry | 352740 | Ocular albinism with congenital sensorineural deafness
orphaentry | 353356 | Vasoproliferative tumor of the retina
orphaentry | 353344 | Idiopathic macular telangiectasia type 1
orphaentry | 353351 | Idiopathic macular telangiectasia type 3
orphaentry | 353334 | Congenital retinal arteriovenous communication
orphaentry | 353320 | Pyruvate carboxylase deficiency, benign type
orphaentry | 353327 | Congenital myasthenic syndromes with glycosylation defect
orphaentry | 353308 | Pyruvate carboxylase deficiency, infantile type
orphaentry | 353314 | Pyruvate carboxylase deficiency, severe neonatal type
orphaentry | 353298 | Roifman syndrome
orphaentry | 353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion
orphaentry | 353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
orphaentry | 352298 | Genetic muscular channelopathy
orphaentry | 352301 | Disorder of phospholipids, sphingolipids and fatty acids biosynthesis
orphaentry | 352403 | Spectrin-associated autosomal recessive cerebellar ataxia
orphaentry | 352333 | Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome
orphaentry | 352328 | MEGDEL syndrome
orphaentry | 352447 | Progressive external ophthalmoplegia-myopathy-emaciation syndrome
orphaentry | 352312 | Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement

Handlinger tilknyttet webside